Phone:   (+91) - 22442114/15

MISSION & VISION

To surge ahead by riding the crest of innovation in formulation

Achieving Healthcare professional’s satisfaction & delivering products which enable people to live healthier, happier, active & stress free life is the core purpose of our business.

Read more

MD’s DESK

Obsurge has a vision to provide relief from the scourge of disease at an affordable price to the widest possible cross-section of patients. With this in view the organization has identified the therapy gaps and bridged it with innovative formulations fitting squarely intothese gaps.

Read more

QUALITY

Quality has always been our top most priority. All our products are manufactured at WHO: GMP, GMP manufacturing facilities and top most quality Raw Materials and excipients are incorporated into the product for better results and efficacy.

Read more

Welcome to our Website

Obsurge, is now a well known name in the pharmaceutical Industry with its established and trusted brands like SERADIC, DUB - 5 & ANXISET in the Indian Market for more than Half a decade. Obsurge Started with the aim to cater the two most important segment of Medical Industry i.e Obstetrics&Gyn and Surgeons , company got instant success with the drug SERADIC introduced to the world for the first time which received unprecedented support from the medical fraternity and still enjoys top ratings in its category (IMS Health data). Since the inception the organization has grown horizontally throughout in its approach, Geography and the therapeutic segments. Today we cater to almost all the categories and therapies including.


Psychiatry, Eye, Urology, cardiology, Dentisry, ENT, Orthopaedics, Gastroentology, Skin, Neuro apart from Surgeons and Gynaecology segments.


Obsurge has identified the therapy gaps and bridged it with unique formulations fitting squarely into the gaps. Obsurge is committed providing the medical fraternity with new formulations for faster economical and unique treatment of the ailing patients.


read more

Latest News

Anxiset Plus and Anxiset E launched

01 April 2011

Spl P-grade amoxy incorporated in production of Duciclav-625 tab for better stability

01 April 2011

ACTD for NOR-STERON(Northiesterone 5mg) filed in Thailand

02 October 2011

ACTD for Anxiset Filed in Thailand

02 November 2011

Muscodol-P launched

01 November 2012

NACTAB(N-Acetylcystine) for female infertility launched

02 January 2012

Obsurge enters Cardiac and Diabetic Segment with 11 Products

13 February 2013

Launch of AMSURGE-AT(Amlodipine+Atenolol) @ Rs1.40 /tab

03 February 2013

To strengthen our base in the market of anti-inflammatory, Obsurge successfully launched Seradic Plus tablet.

03 February 2013

Obsurge enters Urology segment with URISURGE & URISURGE-D.

06 February 2013

ANxiset now available in Thai market.

03 June 2014

New Dermatology Products registered in Thailand.

01 February 2015

New ACTDs filed, 5 more to be filed by year end In Thailand.

01 February 2015

Anxiset approved by THAI FDA.

04 June 2014

Our Products

Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo

International Market

Pharma /Medical Devices /Food/Cosmetics

Although relatively new in International marketing Obsurge now has experience in handling different challenges that different countries offer... Read more

Useful Link          

                         

Contact            

Head Office

101-102 Aditya Tower,
District Centre, Laxmi Nagar
Delhi -110092

Email : mail@obsurge.com
Telefax: (+91) - 22442114/15

Copyright © 2015 Obsurge. | All Right Reserved
CIN-U24232DL2002PLC113701
AKS WebSoft Consulting Pvt Ltd